Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis

Binu V. John; Akash Doshi; Yangyang Deng; Natalie Mansour; A.Sidne Barritt; Andrew M. Moon; George N. Ioannou; Paul Martin; Hann‐Hsiang Chao; Tamar H. Taddei; David Kaplan; Bassam Dahman

doi:10.1016/s0168-8278(22)00818-2

Related publications

Article2022

Effectiveness of mRNA vaccines in patients with cirrhosis with rising prevalence of SARS-CoV-2 delta variant

Binu V. John, Raphaella Ferreira, Dustin Bastaich, Akash Doshi, Tamar H. Taddei, David Kaplan, Seth A. Spector, Bassam Dahman

Letter2022

COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus

Stavroula Α. Paschou, Vangelis Karalis, Θεοδώρα Ψαλτοπούλου, Ioanna Charitaki, Aimilia D. Sklirou, Vassiliki A. Iconomidou, Vasiliki Vasileiou, Georgia Kassi, Andromachi Vryonidou, Alexander Kokkinos, Nikolaοs Tentolouris, Erifili Hatziaggelaki, Ioannis P. Trougakos, Evangelos Terpos, Meletios A Dimopoulos

Article2021

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Ohad Benjamini, Lior Rokach, Gilad Itchaki, Andrei Braester, Lev Shvidel, Neta Goldschmidt, Shirley Shapira, Najib Dally, Abraham Avigdor, Galia Rahav, Yaniv Lustig, Shirley Shapiro Ben David, Riva Fineman, Alona Paz, Osnat Bairey, Aaron Polliack, Ilana Levy, Tamar Tadmor

Haematologica

Article2021

Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines

Jimin Hwang, Se Bee Lee, Seung Won Lee, Min Ho Lee, Ai Koyanagi, Louis Jacob, Kalthoum Tizaoui, Dong Keon Yon, Jae Il Shin, Lee Smith

Article2021

Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia

Gilad Itchaki, Lior Rokach, Ohad Benjamini, Osnat Bairey, Adi D. Sabag, Helly Vernitsky, Hagai Cohen, Shahar Rotem, Uri Elia, Pia Raanani, Erez Bar‐Haim, Tamar Tadmor

Blood

Effectiveness of COVID-19 viral vector vaccine Ad.26.COV2.S vaccine and comparison with mRNA vaccines in patients with cirrhosis

Discussion(0)

Related publications

Effectiveness of mRNA vaccines in patients with cirrhosis with rising prevalence of SARS-CoV-2 delta variant

COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines

Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia